tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ZVSA Stock Latest News

3 Penny Stocks to Watch Now, 11/7/24
Market News3 Penny Stocks to Watch Now, 11/7/24
6d ago
BNOX
SPPL
ZyVersa Therapeutics highlights published data on islet beta cell function
PremiumThe Fly
ZyVersa Therapeutics highlights published data on islet beta cell function
8d ago
ZVSA
ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
PremiumCompany Announcements
ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
13d ago
8K
ZVSA
ZyVersa highlights review article on inflammasome-induced inflammation
PremiumThe Fly
ZyVersa highlights review article on inflammasome-induced inflammation
15d ago
ZVSA
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
PremiumThe Fly
ZyVersa Therapeutics announces publication of data on obesity, neuroinflammation
22d ago
ZVSA
ZyVersa Therapeutics CEO highlights obesity development plans for IC 100
PremiumThe FlyZyVersa Therapeutics CEO highlights obesity development plans for IC 100
27d ago
ZVSA
ZyVersa Therapeutics forms Scientific Advisory Board
Premium
The Fly
ZyVersa Therapeutics forms Scientific Advisory Board
1M ago
ZVSA
ZyVersa Therapeutics files to sell 478,600 shares of common stock for holders
Premium
The Fly
ZyVersa Therapeutics files to sell 478,600 shares of common stock for holders
2M ago
ZVSA
ZyVersa Therapeutics files $100M mixed securities shelf
PremiumThe Fly
ZyVersa Therapeutics files $100M mixed securities shelf
2M ago
ZVSA
ZyVersa Therapeutics announces publication of data on extracellular ASC
PremiumThe Fly
ZyVersa Therapeutics announces publication of data on extracellular ASC
3M ago
ZVSA
ZyVersa Therapeutics announces publication of data on inflammasome ASC
PremiumThe Fly
ZyVersa Therapeutics announces publication of data on inflammasome ASC
4M ago
ZVSA
ZyVersa selects obesity, related metabolic implications at lead indication
PremiumThe Fly
ZyVersa selects obesity, related metabolic implications at lead indication
4M ago
ZVSA
ZyVersa Therapeutics announces publication on inflammasome ASC
PremiumThe FlyZyVersa Therapeutics announces publication on inflammasome ASC
4M ago
ZVSA
ZyVersa Therapeutics expects cas to fund requirements on month-to-month basis
Premium
The Fly
ZyVersa Therapeutics expects cas to fund requirements on month-to-month basis
6M ago
ZVSA
ZyVersa Therapeutics reports Q1 EPS ($4.53) vs. ($135.88) last year
Premium
The Fly
ZyVersa Therapeutics reports Q1 EPS ($4.53) vs. ($135.88) last year
6M ago
ZVSA
ZVSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ZVSA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
ZVSA
ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
PremiumThe Fly
ZyVersa Therapeutics announces publication on ASC Inhibitor IC 100
7M ago
ZVSA
Zyversa Therapeutics Inc trading halted, news pending
PremiumThe Fly
Zyversa Therapeutics Inc trading halted, news pending
7M ago
ZVSA
ZyVersa Therapeutics Approves Reverse Stock Split
PremiumCompany Announcements
ZyVersa Therapeutics Approves Reverse Stock Split
7M ago
8K
ZVSA
ZyVersa Therapeutics highlights publication on NLRP3 inflammasome inhibition
PremiumThe FlyZyVersa Therapeutics highlights publication on NLRP3 inflammasome inhibition
7M ago
ZVSA
Zyversa Therapeutics’ 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
Premium
Company Announcements
Zyversa Therapeutics’ 1-for-35 Reverse Split: Navigating the Risks to Shareholder Value and Liquidity
8M ago
ZVSA
ZyVersa Therapeutics expects cas to fund requirements on month-to-month basis
Premium
The Fly
ZyVersa Therapeutics expects cas to fund requirements on month-to-month basis
8M ago
ZVSA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >